JP2003531196A5 - - Google Patents

Download PDF

Info

Publication number
JP2003531196A5
JP2003531196A5 JP2001578413A JP2001578413A JP2003531196A5 JP 2003531196 A5 JP2003531196 A5 JP 2003531196A5 JP 2001578413 A JP2001578413 A JP 2001578413A JP 2001578413 A JP2001578413 A JP 2001578413A JP 2003531196 A5 JP2003531196 A5 JP 2003531196A5
Authority
JP
Japan
Prior art keywords
acid
ethyl
hydrogen
methyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001578413A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003531196A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/013246 external-priority patent/WO2001081319A2/en
Publication of JP2003531196A publication Critical patent/JP2003531196A/ja
Publication of JP2003531196A5 publication Critical patent/JP2003531196A5/ja
Pending legal-status Critical Current

Links

JP2001578413A 2000-04-24 2001-04-24 超短時間作用型催眠性バルビツール酸塩 Pending JP2003531196A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19914400P 2000-04-24 2000-04-24
US60/199,144 2000-04-24
PCT/US2001/013246 WO2001081319A2 (en) 2000-04-24 2001-04-24 Ultrashort acting hypnotic barbiturates

Publications (2)

Publication Number Publication Date
JP2003531196A JP2003531196A (ja) 2003-10-21
JP2003531196A5 true JP2003531196A5 (cg-RX-API-DMAC7.html) 2008-06-19

Family

ID=22736404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001578413A Pending JP2003531196A (ja) 2000-04-24 2001-04-24 超短時間作用型催眠性バルビツール酸塩

Country Status (6)

Country Link
US (4) US6387914B2 (cg-RX-API-DMAC7.html)
EP (1) EP1276728A2 (cg-RX-API-DMAC7.html)
JP (1) JP2003531196A (cg-RX-API-DMAC7.html)
AU (2) AU5723001A (cg-RX-API-DMAC7.html)
CA (1) CA2404898A1 (cg-RX-API-DMAC7.html)
WO (1) WO2001081319A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6387914B2 (en) * 2000-04-24 2002-05-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
US7049326B2 (en) * 2000-05-12 2006-05-23 The University Of Toledo Method and compositions for temporarily incapacitating subjects
US6750238B1 (en) * 2000-05-12 2004-06-15 The University Of Toledo Aralkyl ester soft drugs
US6756047B2 (en) * 2000-05-12 2004-06-29 The University Of Toledo Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
US10537061B2 (en) * 2010-02-26 2020-01-21 Cnh Industrial America Llc System and method for controlling harvest operations
US20150190410A1 (en) * 2012-07-16 2015-07-09 Dignity Health Use of creatine and phosphocreatine in the treatment of epilepsy and alcohol addiction
EP3193862B1 (en) 2014-09-16 2023-10-18 Igc Pharma Ip, Llc Topical cannabinoid composition for treating arthritic pain
CA2974895A1 (en) 2015-01-25 2016-07-28 India Globalization Capital, Inc. Composition and method for treating seizure disorders
US10596159B2 (en) 2015-08-12 2020-03-24 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
US11351152B2 (en) 2016-06-15 2022-06-07 India Globalization Capital, Inc. Method and composition for treating seizure disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CS176667B1 (cg-RX-API-DMAC7.html) * 1975-02-17 1977-06-30
IL73840A (en) * 1983-12-19 1988-11-15 Uniroyal Chem Co Inc 2-thio-5-(thio)carbamoyl barbituric acid derivatives,their preparation and pharmaceutical compositions containing them
ES2128314T3 (es) * 1989-11-14 1999-05-16 Sloan Kettering Inst Cancer Nuevos inductores potentes de diferenciacion terminal y metodo de utilizacion de los mismos.
CH678394A5 (cg-RX-API-DMAC7.html) * 1990-08-22 1991-09-13 Cerny Erich H
US5414085A (en) * 1992-04-06 1995-05-09 Biosite Diagnostics, Inc. Barbiturate derivatives and protein and polypeptide barbiturate derivative conjugates and labels
JPH06214344A (ja) * 1992-10-22 1994-08-05 Konica Corp ハロゲン化銀写真感光材料
JPH07120865A (ja) * 1993-10-21 1995-05-12 Konica Corp ハロゲン化銀写真感光材料
AU746853B2 (en) * 1997-06-21 2002-05-02 Roche Diagnostics Gmbh Barbituric acid derivatives with antimetastatic and antitumor activity
US6387914B2 (en) 2000-04-24 2002-05-14 Aryx Therapeutics Ultrashort acting hypnotic barbiturates

Similar Documents

Publication Publication Date Title
KR890011853A (ko) 치환된 피롤, 피라졸 및 트리아졸 안지오텐신ⅱ 길항제
RU2436780C2 (ru) Производные 5-фенилтиазола и их применение в качестве ингибиторов рi3 киназы
CA2440473A1 (en) Metalloproteinase inhibitors
JP2001526218A5 (cg-RX-API-DMAC7.html)
JP2003531196A5 (cg-RX-API-DMAC7.html)
JP2002502874A5 (cg-RX-API-DMAC7.html)
RU96115142A (ru) Производные 5-(2-имидазолиниламино)бензимидазола, их получение и применение в качестве агонистов альфа-2-адреноцепторов
KR880002840A (ko) 이미다졸 화합물, 그의 제조 방법 및 이것으로 되는 제약 조성물
EP1797878A3 (en) Benzothiazole derivatives
EP2228064A3 (en) Pharmaceutical composition containing glycopyrrolate and a beta2 adrenoceptor agonist
CA2565813A1 (en) Substituted methyl aryl or heteroaryl amide compounds
SK95093A3 (en) Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b
JP2006501201A5 (cg-RX-API-DMAC7.html)
RU2006146632A (ru) Производные хиназолинона, полезные в качестве ванилоидных антагонистов
JP2002519425A5 (cg-RX-API-DMAC7.html)
CA2539738A1 (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
RU2000123169A (ru) Бензотиадиазолы и их производные
CA2440014A1 (en) Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
RU2001105092A (ru) Имидазольные соединения и их применение в качестве ингибиторов аденозиндезаминазы
JP2004525178A5 (cg-RX-API-DMAC7.html)
CA2643005A1 (en) Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
JP2004525183A5 (cg-RX-API-DMAC7.html)
CA2433039A1 (en) Agent for therapeutic and prophylactic treatment of neuropathic pain
JP2005526773A5 (cg-RX-API-DMAC7.html)
RU2005121125A (ru) Аминоалкоксииндолы, как лиганды рецептора 5-нт6, для лечения заболеваний цнс